OTCMKTS:CBDL CBD Life Sciences Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CBD Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.0002 0.00 (0.00%) (As of 07/5/2022 12:00 AM ET) Add Compare Share Today's Range$0.00▼$0.0050-Day Range N/A52-Week Range$0.00▼$0.00Volume64.23 million shsAverage Volume76.56 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest CBD Life Sciences MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthyDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.22 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for CBD Life Sciences. Previous Next 4.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverCBD Life Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CBD Life Sciences has recently decreased by 12.50%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCBD Life Sciences does not currently pay a dividend.Dividend GrowthCBD Life Sciences does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CBDL. Previous Next 1.1 News and Social Media Coverage News SentimentCBD Life Sciences has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for CBD Life Sciences this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CBD Life Sciences insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CBDL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CBD Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address About CBD Life SciencesCBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.Read More CBDL Stock News HeadlinesJune 30, 2022 | seekingalpha.comCBD Life Sciences launches new lab at CBD VaultMay 19, 2022 | finanznachrichten.deCBD Life Sciences Inc.: CBD Life Sciences, Inc. Set to Attend White Label Expo in Las VegasMay 19, 2022 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Set to Attend White Label Expo in Las VegasMay 17, 2022 | markets.businessinsider.comGood News for Daily CBD Consumers: Charlotte's Web Reports Second Cohort of CBD Safety Study Finds Zero Liver Toxicity and No DrowsinessMay 12, 2022 | msn.comTrial by Fire: A Crash Course on CBD With Charlotte’s WebMay 10, 2022 | benzinga.comCBD Global Announces Management Cease Trade OrderApril 5, 2022 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Debuts New Delta-9 GummiesMarch 10, 2022 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Set to Present at ERRL Cup Cannabis EventFebruary 11, 2022 | benzinga.comLBC BioscienceFebruary 10, 2022 | finanznachrichten.deCBD Life Sciences Inc.: CBD Life Sciences, Inc. (CBDL) Announces Launch of Vegan Gummies on Amazon PlatformFebruary 10, 2022 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Announces Launch of Vegan Gummies on Amazon PlatformFebruary 2, 2022 | seekingalpha.comCBD Life Sciences to start production of HHC productsFebruary 2, 2022 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Introduces Production of HHC ProductsJanuary 26, 2022 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Releases Letter to ShareholdersDecember 21, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Looking to expand its Hemp Product Line in EuropeDecember 2, 2021 | finanznachrichten.deCBD Life Sciences Inc.: CBD Life Sciences, Inc. (CBDL) Introduces First CBD Vending Machine at Premium Outlet MallDecember 2, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Introduces First CBD Vending Machine at Premium Outlet MallNovember 18, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Set to Start Accepting Bitcoin for CBD on Its E-Commerce StoreNovember 10, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Announces Approval of Industrial Hemp Grower LicenseNovember 5, 2021 | finanznachrichten.deCBD Life Sciences Inc.: CBD Life Sciences, Inc. (CBDL) Makes Progress to Triple Its Cartridge Production for Multinational CompaniesNovember 3, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Makes Progress to Triple Its Cartridge Production for Multinational CompaniesOctober 21, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Set to Expand High Premium CBD DistillateOctober 13, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Debuts Kratom for Treatment of Pain and Opioid WithdrawalSeptember 29, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Launches on eBay Featuring Hemp Skincare LineSeptember 22, 2021 | finance.yahoo.comCBD Life Sciences, Inc. (CBDL) Set to Launch Products on Alibaba PlatformSee More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers-Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CBDL CUSIPN/A CIK1776073 Webwww.optiumcyber.com Phone(480) 410-6780FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A CBD Life Sciences Frequently Asked Questions How has CBD Life Sciences' stock price performed in 2022? CBD Life Sciences' stock was trading at $0.0002 at the beginning of 2022. Since then, CBDL stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2022 here. Are investors shorting CBD Life Sciences? CBD Life Sciences saw a decline in short interest in May. As of May 31st, there was short interest totaling 800 shares, a decline of 93.4% from the May 15th total of 12,200 shares. Based on an average daily volume of 113,948,200 shares, the days-to-cover ratio is presently 0.0 days. View CBD Life Sciences' Short Interest. Who are CBD Life Sciences' key executives? CBD Life Sciences' management team includes the following people: Ms. Lisa Anne Nelson, Pres, CEO, CFO & Director (Age 55, Pay $240k)Ms. Vicki Martinez, Sec. & DirectorMs. Mercedes Sturm, Treasurer & Director Who are some of CBD Life Sciences' key competitors? Some companies that are related to CBD Life Sciences include 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRHF), Acreage (ACRDF), AFT Pharmaceuticals (AFP), Agra Ventures (AGFAF), Agraflora Organics International (AGRA), Aleafia Health (ALEAF), American Green (ERBB), Ascend Wellness (AWWH), Australian Primary Hemp (APH), BellRock Brands (DXBRF) and Benchmark (BHCCF). View all of CBDL's competitors. What is CBD Life Sciences' stock symbol? CBD Life Sciences trades on the OTCMKTS under the ticker symbol "CBDL." How do I buy shares of CBD Life Sciences? Shares of CBDL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CBD Life Sciences' stock price today? One share of CBDL stock can currently be purchased for approximately $0.00. How many employees does CBD Life Sciences have? CBD Life Sciences employs 7 workers across the globe. How can I contact CBD Life Sciences? The official website for CBD Life Sciences is www.optiumcyber.com. The company can be reached via phone at (480) 410-6780. This page (OTCMKTS:CBDL) was last updated on 7/6/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
